NeuBase Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $33,318,339.
Profit Margin
| 2013 | 0 | -5.65M | |
|---|---|---|---|
| 2014 | 0 | -9.13M | |
| 2015 | 0 | -15.19M | |
| 2016 | 0 | -25.76M | |
| 2017 | 0 | -23.81M | |
| 2018 | 0 | -13.23M | |
| 2019 | 0 | -27.08M | |
| 2020 | 0 | -17.26M | |
| 2021 | 0 | -25.66M | |
| 2022 | 0 | -34.23M |
NBSE Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.26M | 575.52K | 280.46K | 128.37K | 13.90M | 23.78M | 24.59M | 0 | 0 | 0 |
Gross profit | -1.26M | -575.52K | -280.46K | -128.37K | -13.90M | -23.78M | -24.59M | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 21.44M | 14.36M | 6.94M | 17.24M | 4.31M | 17.40M | 16.46M | 8.77M | 3.99M | 2.61M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 33.31M | 26.56M | 17.06M | 26.33M | 9.07M | 23.85M | 25.30M | 17.46M | 9.12M | 4.62M |
Operating income | -33.31M | -26.56M | -17.06M | -26.33M | -13.90M | -23.78M | -24.59M | -17.80M | -9.12M | -4.62M |
Other income (expenses), net | -458.11K | 1.15M | -315.21K | -621.84K | -4.23M | -30.92K | -471.98K | 2.60M | 0 | -1.02M |
Income before tax | -33.77M | -25.40M | -17.38M | -26.95M | -13.23M | -23.81M | -25.76M | -15.19M | -9.13M | -5.65M |
Income tax expense | 458.11K | 258.10K | -123.26K | 128.95K | 8.98M | -109.24K | 459.88K | -2.37M | -8.47K | 1.02M |
Net income | -34.23M | -25.66M | -17.26M | -27.08M | -13.23M | -23.81M | -25.76M | -15.19M | -9.13M | -5.65M |
Earnings per share | ||||||||||
Basic EPS | -21.08 | -18.8 | -17.6 | -65.49 | -93.57 | -212.74 | -328.76 | -214.02 | -164.95 | -120.86 |
Diluted EPS | -21.08 | -18.8 | -17.6 | -65.49 | -93.57 | -212.74 | -328.76 | -214.02 | -164.95 | -120.86 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |